​Strategic advisory firm.
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | VERTEX PHARMACEUTICALS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 | — | |
| 2026 | SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATION |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$30,000 | — | |
| 2026 | INDEPENDENCE BLUE CROSS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$40,000 | — | |
| 2026 | HUMANA, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$60,000 | — | |
| 2026 | ELEVANCE HEALTH, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$60,000 | — | |
| 2026 | CVS HEALTH (AND SUBSIDIARIES) |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$70,000 | — | |
| 2026 | CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATES |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 | — | |
| 2026 | CENTENE CORPORATIONS |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$30,000 | — | |
| 2026 | CAREVISO INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$20,000 | — | |
| 2026 | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$40,000 | — |
| Client | Filings | Total Income |
|---|---|---|
| ELEVANCE HEALTH, INC. | 23 | $1,180,000 |
| BLUE CROSS AND BLUE SHIELD ASSOCIATION | 23 | $1,090,000 |
| CAREVISO INC. | 22 | $380,000 |
| CVS HEALTH (AND SUBSIDIARIES) | 21 | $980,000 |
| HUMANA, INC. | 18 | $710,000 |
| BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 18 | $620,000 |
| BETTER SOLUTIONS FOR HEALTHCARE | 13 | $600,000 |
| AMERICAN HEART ASSOCIATION | 13 | $550,000 |
| BLOOD CANCER UNITED | 9 | $290,000 |
| MARIUS PHARMACEUTICALS LLC | 9 | $220,000 |
| NOVAVAX, INC. | 9 | $160,000 |
| CENTENE CORPORATIONS | 7 | $180,000 |
| OLIVE AI | 5 | $100,000 |
| CIGNA CORPORATE SERVICES, LLC AND ITS AFFILIATES | 3 | $100,000 |
| VERTEX PHARMACEUTICALS | 3 | $100,000 |
| INDEPENDENCE BLUE CROSS | 3 | $80,000 |
| AIS HEALTHCARE | 3 | $80,000 |
| SALT POINT STRATEGIES ON BEHALF OF THE RITEDOSE CORPORATION | 3 | $60,000 |
| FARRAGUT PARTNERS LLP ON BEHALF OF JOHNSON & JOHNSON SERVICES INC. | 3 | $40,000 |
| Name | Disclosed Prior Position |
|---|---|
| ADAM BUCKALEW | Deputy Health Policy Director, U.S. Senate Committee on Health, Education, Labor and Pensions (HELP); Deputy Chief Heal… |
| VERONICA JACKSON | Director, Strategic Planning, Office of the Assistant Secretary for Public Affairs, HHS |